Obesity & Metabolic
The advent of novel anti-obesity medications, led by GLP-1-based treatments, is transforming the management of obesity and related conditions…
Having tracked the obesity market for many years, Ipsos has accelerated our work in this dynamic space in line with client need. Our global portfolio includes:
Custom Research, Market Access & Advisory Services
From a firm foundation of therapy area expertise, market knowledge, and unrivalled access to all relevant stakeholders, we conduct qual and quant custom research, ethnographic studies, social intelligence, market access and strategic advisory services to answer business questions across the obesity and metabolic product lifecycles.
Global Healthcare Monitors (Real-world Data + Stakeholder Perceptions)
Our expert-led multi-client monitors provide an evolving 360⁰ view of the dynamic obesity landscape, and include:
- Ipsos Global Obesity & Cardiometabolic Disease Therapy Monitor
- Ipsos Global Consumer Obesity / GLP-1 Monitor
- Ipsos GLP-1 PersonaBot (interactive GLP-1 consumer segment personas)
- Ipsos GLP-1 Market Sizing Monitor
- Ipsos MASH Therapy Monitor
- Ipsos ASCVD Lpa Monitor
Learn more: Ipsos Monitors the Obesity Treatment Revolution
Learn more: Ipsos Launches GLP-1 PersonaBot
Recent thought leadership
PoV: Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
PoV: Empowered Consumers Lead The Obesity Market
Podcast: Obesity: The Big Picture
Webinar Recording: (HIMSS) Innovations For More Equitable Obesity Care
PoV: Predicting Opportunity in Emerging Therapies
PoV: GLP-1s Beyond Weight Loss
Paper: Revolutionizing Diabetes Care: Rise of the Digital Ecosystem
Talk to us about your obesity business questions.